News

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...
The FDA and Novo Nordisk are warning of counterfeit Ozempic® (semaglutide) which could pose a safety risk. The FDA and ...
A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug. Matthew ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...
Both injectable and oral forms of semaglutide are already approved by the U.S. Food and Drug Administration but the oral formulation’s impact on cardiovascular outcomes has not previously been ...
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar ...
Novo Nordisk filed for approval of an oral, 25-mg formulation of semaglutide “earlier this year,” according to a company spokesperson.
“Semaglutide originally came to market as a once-weekly injectable where it's now approved for use for the treatment of hyperglycemia and to reduce cardiovascular risk in people with type two diabetes ...
Semaglutide, available in both injectable and oral forms, has drawn recent attention not only for its blood sugar-lowering power, but also for weight loss and even reduction in alcohol cravings.
In the randomized STRIDE trial, a year of semaglutide (Ozempic, Wegovy) injections increased the walking ability of people with type 2 diabetes (T2D) and lower limb PAD by 21%, a significant ...
‘Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain’ Semaglutide: A Key ...
PLAINSBORO, N.J., April 14, 2025 /PRNewswire/ -- Novo Nordisk has become aware of several hundred units of Ozempic ® (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized ...